289 related articles for article (PubMed ID: 28155970)
21. ER+ /PR+ /TFF3+ /IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: a study of 401 cases.
Mhawech-Fauceglia P; Yan L; Liu S; Pejovic T
Histopathology; 2013 Jun; 62(7):976-85. PubMed ID: 23570281
[TBL] [Abstract][Full Text] [Related]
22. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
[TBL] [Abstract][Full Text] [Related]
23. High-grade Endometrial Carcinomas: Morphologic and Immunohistochemical Features, Diagnostic Challenges and Recommendations.
Murali R; Davidson B; Fadare O; Carlson JA; Crum CP; Gilks CB; Irving JA; Malpica A; Matias-Guiu X; McCluggage WG; Mittal K; Oliva E; Parkash V; Rutgers JKL; Staats PN; Stewart CJR; Tornos C; Soslow RA
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S40-S63. PubMed ID: 30550483
[TBL] [Abstract][Full Text] [Related]
24. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis.
Reid-Nicholson M; Iyengar P; Hummer AJ; Linkov I; Asher M; Soslow RA
Mod Pathol; 2006 Aug; 19(8):1091-100. PubMed ID: 16648864
[TBL] [Abstract][Full Text] [Related]
25. WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium.
Acs G; Pasha T; Zhang PJ
Int J Gynecol Pathol; 2004 Apr; 23(2):110-8. PubMed ID: 15084838
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical expression of galectin-3 is significantly associated with grade, stage and differentiation of endometrial carcinomas.
Al-Maghrabi J; Abdelrahman AS; Ghabrah T; Butt NS; Al-Maghrabi B; Khabaz MN
Pathol Res Pract; 2017 Apr; 213(4):348-352. PubMed ID: 28215640
[TBL] [Abstract][Full Text] [Related]
28. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
29. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
[TBL] [Abstract][Full Text] [Related]
30. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
31. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
Schlosshauer PW; Ellenson LH; Soslow RA
Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
[TBL] [Abstract][Full Text] [Related]
32. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases.
Lu B; Chen Q; Zhang X; Cheng L
Diagn Pathol; 2016 Jun; 11(1):46. PubMed ID: 27260518
[TBL] [Abstract][Full Text] [Related]
33. Histologic and immunohistochemical analyses of endometrial carcinomas: experiences from endometrial biopsies in 358 consultation cases.
Wei JJ; Paintal A; Keh P
Arch Pathol Lab Med; 2013 Nov; 137(11):1574-83. PubMed ID: 24168495
[TBL] [Abstract][Full Text] [Related]
34. Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.
Fadare O; Parkash V; Gwin K; Hanley KZ; Jarboe EA; Liang SX; Quick CM; Zheng W; Rawish KR; Hecht JL; Desouki MM
Hum Pathol; 2013 Dec; 44(12):2814-21. PubMed ID: 24119561
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of hepatocyte nuclear factor 1-beta immunoreactivity in endometrial carcinomas: lack of specificity for endometrial clear cell carcinoma.
Fadare O; Liang SX
Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):580-7. PubMed ID: 22495362
[TBL] [Abstract][Full Text] [Related]
36. Despite Diagnostic Morphology, Many Mixed Endometrial Carcinomas Show Unexpected Immunohistochemical Staining Patterns.
Matrai CE; Pirog EC; Ellenson LH
Int J Gynecol Pathol; 2018 Sep; 37(5):405-413. PubMed ID: 29019871
[TBL] [Abstract][Full Text] [Related]
37. Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type.
Clarke BA; Gilks CB
J Clin Pathol; 2010 May; 63(5):410-5. PubMed ID: 20418232
[TBL] [Abstract][Full Text] [Related]
38. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
Lax SF; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
[TBL] [Abstract][Full Text] [Related]
39. Role of WT1, B-cell lymphoma 2, Ki-67 (Mib1), and Her2/Neu as diagnostic and prognostic immunomarkers in ovarian serous and endometroid carcinoma.
Mondal SK; Basak B; Bhattacharya S; Panda UK
J Cancer Res Ther; 2021; 17(1):164-169. PubMed ID: 33723149
[TBL] [Abstract][Full Text] [Related]
40. Reproducibility of histological cell type in high-grade endometrial carcinoma.
Han G; Sidhu D; Duggan MA; Arseneau J; Cesari M; Clement PB; Ewanowich CA; Kalloger SE; Köbel M
Mod Pathol; 2013 Dec; 26(12):1594-604. PubMed ID: 23807777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
